Document Detail

Inhibition of tumor-associated fatty acid synthase hyperactivity induces synergistic chemosensitization of HER -2/ neu -overexpressing human breast cancer cells to docetaxel (taxotere).
MedLine Citation:
PMID:  14999148     Owner:  NLM     Status:  MEDLINE    
The lipogenic enzyme fatty acid synthase (FAS) is differentially overexpressed and hyperactivated in a biologically aggressive subset of breast carcinomas and minimally in most normal adult tissues, rendering it an interesting target for antineoplastic therapy development. Recently, a molecular connection between the HER -2/ neu (c- erb B-2) oncogene and FAS has been described in human breast cancer cells. Here, we examined the relationship between breast cancer-associated FAS hyperactivity and HER -2/ neu -induced breast cancer chemoresistance to taxanes. Co-administration of docetaxel (Taxotere) and the mycotoxin cerulenin, a potent and non-competitive inhibitor of FAS activity, demonstrated strong synergism in HER -2/ neu -overexpressing and docetaxel-resistant SK-Br3 cells, modest synergism in moderately HER -2/ neu -expressing MCF-7 cells, and it showed additive effects in low HER -2/ neu -expressing and docetaxel-sensitive MDA-MB-231 cells. Sequential exposure to cerulenin followed by docetaxel again yielded strong synergism in SK-Br3 cells, whereas antagonistic and moderate synergistic interactions were observed in MCF-7 and MDA-MB-231 cells, respectively. Importantly, inhibition of FAS activity dramatically decreased the expression of HER -2/ neu oncogene in SK-Br3 breast cancer cells. To the best of our knowledge this is the first study demonstrating that FAS is playing an active role in HER -2/ neu -induced breast cancer chemotherapy resistance.
Javier A Menendez; Ruth Lupu; Ramon Colomer
Related Documents :
23768888 - Breast ultrasound: current concepts.
18818108 - Taxol synergizes with antioxidants in inhibiting hormal refractory prostate cancer cell...
7896458 - Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alph...
12218458 - Real-time quantitative analysis of telomerase activity in breast tumor specimens using ...
10669248 - In vivo 1h mr spectroscopy of human head and neck lymph node metastasis and comparison ...
19419468 - Uptake of pyrene in a breast-fed child of a mother treated with coal tar.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Breast cancer research and treatment     Volume:  84     ISSN:  0167-6806     ISO Abbreviation:  Breast Cancer Res. Treat.     Publication Date:  2004 Mar 
Date Detail:
Created Date:  2004-03-04     Completed Date:  2004-06-17     Revised Date:  2013-05-28    
Medline Journal Info:
Nlm Unique ID:  8111104     Medline TA:  Breast Cancer Res Treat     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  183-95     Citation Subset:  IM    
Department of Medicine, Evanston Northwestern Healthcare Research Institute, Evanston, IL 60201, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antifungal Agents / administration & dosage
Antineoplastic Agents, Phytogenic / administration & dosage*
Breast Neoplasms / drug therapy,  genetics
Cell Division / drug effects
Cell Line, Tumor
Cerulenin / administration & dosage
Drug Resistance, Neoplasm / genetics*
Fatty Acid Synthetase Complex / antagonists & inhibitors*
Genes, erbB-2 / genetics*
Taxoids / administration & dosage*
Reg. No./Substance:
0/Antifungal Agents; 0/Antineoplastic Agents, Phytogenic; 0/Taxoids; 15H5577CQD/docetaxel; 17397-89-6/Cerulenin; EC 6.-/Fatty Acid Synthetase Complex

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Preclinical therapy of breast cancer with a radioiodinated humanized anti-EGP-1 monoclonal antibody:...
Next Document:  RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast c...